The MIT Jameel Clinic unveils Boltz-1, the first commercially-available, open-source protein structure prediction model that achieves the same level of accuracy as AI-powered protein prediction model AlphaFold3.
In MIT News, Mathai Mammen, CEO and president of Parabilis Medicines, describes Boltz-1 as a “breakthrough” model: “By open-sourcing this advance, the MIT Jameel Clinic and collaborators are democratising access to cutting-edge structural biology tools.”